Regulatory › Drugs@FDA › History › NDA021488 Drugs@FDA application timeline
NDA021488 17 dated FDA-coded AP submissions from 2003-02-13 through 2026-05-06, connected to 16 source-defined action assignments and 35 official document links.
17 Dated AP submissions
16 Action assignments
35 Official documents
0 Exact enforcement reports
1 Reviewed profile mappings
Reporting boundary This history reports exact Drugs@FDA submission status dates, source-defined action labels, and official document metadata for applications already selected by PeptideScanner. FDA's AP code and action labels are source metadata; this page does not interpret approval scope, reproduce document text, establish safety or effectiveness, or provide medical guidance. Document links open FDA-hosted material; PeptideScanner does not copy or summarize their contents.
Reviewed identity mapping
Connected peptide profiles Newest first
Submission and document chronology 17 submissions 2026-05-06 · status AP
Supplement 57 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2026-05-12 · FDA document 85889 Letter ↗ 2026-05-08 · FDA document 85854 2025-02-24 · status AP
Supplement 53 FDA action labels Labeling-Package Insert
2 official documents Letter ↗ 2025-02-25 · FDA document 81371 Label ↗ 2025-02-25 · FDA document 81346 2025-02-04 · status AP
Supplement 52 FDA action labels Labeling-Container/Carton Labels
2 official documents Label ↗ 2025-02-06 · FDA document 81015 Letter ↗ 2025-02-06 · FDA document 80965 2024-05-21 · status AP
Supplement 50 FDA action labels Labeling-Container/Carton Labels
2 official documents Letter ↗ 2024-05-22 · FDA document 78531 Label ↗ 2024-05-22 · FDA document 78530 2024-01-23 · status AP
Supplement 48 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2024-01-25 · FDA document 77295 Letter ↗ 2024-01-24 · FDA document 77287 2023-07-20 · status AP
Supplement 45 FDA action labels Efficacy-New Indication
2 official documents Label ↗ 2023-07-21 · FDA document 74862 Letter ↗ 2023-07-21 · FDA document 74852 2023-07-20 · status AP
Supplement 44 FDA action labels Efficacy-Labeling Change With Clinical Data
2 official documents Label ↗ 2023-07-21 · FDA document 74861 Letter ↗ 2023-07-21 · FDA document 74851 2019-02-15 · status AP
Supplement 36 FDA action labels Labeling-Package Insert
2 official documents Letter ↗ 2019-02-21 · FDA document 57735 Label ↗ 2019-02-19 · FDA document 57698 2016-02-29 · status AP
Supplement 30 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2016-03-03 · FDA document 37058 Letter ↗ 2016-03-02 · FDA document 5526 2014-10-10 · status AP
Supplement 27 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2014-10-15 · FDA document 37057 Letter ↗ 2014-10-14 · FDA document 5525 2013-02-27 · status AP
Supplement 25 FDA action labels Labeling-Package Insert
2 official documents Letter ↗ 2013-03-01 · FDA document 27921 Label ↗ 2013-03-01 · FDA document 15589 2011-04-08 · status AP
Supplement 17 FDA action labels Labeling-Package Insert
2 official documents Letter ↗ 2011-04-11 · FDA document 27920 Label ↗ 2011-04-11 · FDA document 15588 2011-01-14 · status AP
Supplement 16 FDA action labels Labeling
2 official documents Letter ↗ 2011-01-20 · FDA document 27919 Label ↗ 2011-01-20 · FDA document 15587 2010-10-05 · status AP
Supplement 15 FDA action labels Labeling-Package Insert
2 official documents Letter ↗ 2010-10-13 · FDA document 27918 Label ↗ 2010-10-12 · FDA document 15586 2007-11-08 · status AP
Supplement 10 FDA action labels Labeling
2 official documents Letter ↗ 2007-11-19 · FDA document 5524 Label ↗ 2007-11-13 · FDA document 37056 2004-01-12 · status AP
Supplement 2 FDA action labels Labeling
1 official document 2003-02-13 · status AP
Original submission 1 No source action-type assignment was retained for this submission.
4 official documents Source archive dated 2026-08-24; observed 2026-08-24T21:23:49.000Z; reviewed 2026-08-24. Observation SHA-256: 6166fd223ef126a19e8ebfdaafe1fbf7c330a4cf7153cef00fb6c52c45ef757b.